1. Home
  2. ALDX vs FORR Comparison

ALDX vs FORR Comparison

Compare ALDX & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • FORR
  • Stock Information
  • Founded
  • ALDX 2004
  • FORR 1983
  • Country
  • ALDX United States
  • FORR United States
  • Employees
  • ALDX N/A
  • FORR 1744
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • FORR Diversified Commercial Services
  • Sector
  • ALDX Health Care
  • FORR Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • FORR Nasdaq
  • Market Cap
  • ALDX 304.9M
  • FORR 293.9M
  • IPO Year
  • ALDX 2014
  • FORR 1996
  • Fundamental
  • Price
  • ALDX $5.40
  • FORR $15.38
  • Analyst Decision
  • ALDX Strong Buy
  • FORR
  • Analyst Count
  • ALDX 2
  • FORR 0
  • Target Price
  • ALDX $10.00
  • FORR N/A
  • AVG Volume (30 Days)
  • ALDX 394.0K
  • FORR 45.9K
  • Earning Date
  • ALDX 03-06-2025
  • FORR 02-11-2025
  • Dividend Yield
  • ALDX N/A
  • FORR N/A
  • EPS Growth
  • ALDX N/A
  • FORR N/A
  • EPS
  • ALDX N/A
  • FORR N/A
  • Revenue
  • ALDX N/A
  • FORR $442,518,000.00
  • Revenue This Year
  • ALDX N/A
  • FORR N/A
  • Revenue Next Year
  • ALDX N/A
  • FORR $1.57
  • P/E Ratio
  • ALDX N/A
  • FORR N/A
  • Revenue Growth
  • ALDX N/A
  • FORR N/A
  • 52 Week Low
  • ALDX $2.71
  • FORR $13.96
  • 52 Week High
  • ALDX $6.55
  • FORR $25.88
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 60.04
  • FORR 49.54
  • Support Level
  • ALDX $4.95
  • FORR $15.26
  • Resistance Level
  • ALDX $5.10
  • FORR $15.63
  • Average True Range (ATR)
  • ALDX 0.24
  • FORR 0.47
  • MACD
  • ALDX 0.04
  • FORR 0.11
  • Stochastic Oscillator
  • ALDX 85.06
  • FORR 77.17

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About FORR Forrester Research Inc.

Forrester Research Inc is a United States-based company that provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.

Share on Social Networks: